Sensus Healthcare, Inc.
SRTS
$3.30
$0.072.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -68.69% | -59.32% | -62.20% | -22.12% | -20.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -68.69% | -59.32% | -62.20% | -22.12% | -20.82% |
| Cost of Revenue | -65.53% | -39.77% | -48.96% | 15.89% | 15.62% |
| Gross Profit | -73.51% | -77.24% | -73.30% | -48.23% | -46.47% |
| SG&A Expenses | -15.85% | -14.45% | -17.18% | 20.16% | 31.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.92% | -29.46% | -28.69% | 28.72% | 27.57% |
| Operating Income | -63.66% | -64.70% | -282.39% | -271.84% | -198.03% |
| Income Before Tax | -74.03% | -71.93% | -253.02% | -235.79% | -180.33% |
| Income Tax Expenses | 886.45% | -1,560.91% | -57.56% | -362.25% | -224.87% |
| Earnings from Continuing Operations | -743.68% | -2.10% | -304.85% | -177.61% | -164.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -743.68% | -2.10% | -304.85% | -177.61% | -164.33% |
| EBIT | -63.66% | -64.70% | -282.39% | -271.84% | -198.03% |
| EBITDA | -67.79% | -66.48% | -268.14% | -259.63% | -191.60% |
| EPS Basic | -737.01% | -1.33% | -305.07% | -177.69% | -164.21% |
| Normalized Basic EPS | -72.55% | -70.59% | -253.21% | -235.94% | -180.24% |
| EPS Diluted | -737.01% | 0.00% | -305.07% | -185.71% | -164.21% |
| Normalized Diluted EPS | -72.55% | -70.59% | -254.03% | -236.14% | -180.43% |
| Average Basic Shares Outstanding | 0.87% | 0.74% | -0.05% | -0.01% | 0.13% |
| Average Diluted Shares Outstanding | 0.87% | 0.74% | -0.70% | -0.16% | -0.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |